Maze Therapeutics
Trade Maze Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MAZE
Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM diseases. Its pipeline includes the Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process to refer a variant functionalization.
MAZE Key Statistics
Stock Snapshot
With a market cap of 1.48B, Maze Therapeutics(MAZE) trades at $26.65. The stock has a price-to-earnings ratio of -10.38.
On 2026-06-24, Maze Therapeutics(MAZE) stock moved within a range of $26.30 to $27.01. With shares now at $26.65, the stock is trading +1.3% above its intraday low and -1.3% below the session's peak.
Trading activity shows a volume of 643.47K, compared to an average daily volume of 687.91K.
The stock's 52-week range extends from a low of $9.83 to a high of $53.65.
The stock's 52-week range extends from a low of $9.83 to a high of $53.65.
MAZE News
...
Analyst ratings
100%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.